New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs Editor: Mauro Maccarrone
Natural Compounds and Synthetic Drugs to Target Type-2 Cannabinoid (CB2 ) Receptor
Inhibition of NAPE-PLD Activity by Natural Compounds and Synthetic Drugs, and Its Biological Relevance
Natural Compounds and Synthetic Drugs to Target FAAH Enzyme
Small-molecule Inhibitors of Endocannabinoid Transport and Trafficking
Subject Index
Publication details
- Print publication date
- 16 Nov 2020
- Copyright year
- 2021
- Print ISBN
- 978-1-78801-801-2
- PDF eISBN
- 978-1-83916-075-2
- ePub eISBN
- 978-1-83916-085-1
About this book
Legalization of cannabis extracts around the world has led to a resurgence of interest into research surrounding endocannabinoids (eCBs) and the endocannabinoid system. This system is formed of a complex array of receptors, metabolic enzymes and transporters that finely tune the manifold biological activities of eCBs and there is an urgent need for the development of selective drugs to dissect the contribution of eCBs to the aetiology of various diseases. New Tools to Interrogate Endocannabinoid Signalling comprehensively covers the innovative research into both natural and synthetic compounds that affect this pathway and taking a target-based approach, assesses their potential for therapeutic use. With contributions from global leaders in the field, this timely volume will be a valuable resource to pharmaceutical researchers and medicinal chemists working in natural products and endocannabinoid drug discovery in academia and industry.